Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00748085 · ClinicalTrials.gov registry record · NA
CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)
A NA study, sponsored by CSA Medical.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT00748085 is a NA study that was terminated before completion, run by CSA Medical. The registered enrollment target is 5 participants.
The verdict
NCT00748085, a NA study, was terminated before completion, sponsored by CSA Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, and tissue effect of the CryoSpray Ablation(TM) System (CryoSpray Ablation(TM), "CSA" or "cryospray therapy") at multiple centers to treat malignant airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB)
Interventions
- DEVICE CryoSpray Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-10 |
| Est. Completion | 2009-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00748085
The ClinicalTrials.gov registry entry for NCT00748085 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CSA Medical, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CryoSpray Ablation is the first listed.
NCT00748085 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00748085 about?
NCT00748085 is a clinical study titled "CryoSpray Ablation(tm)in Malignant Airway Disease to Determine Safety, and Tissue Effect in the Lung (ICE the MAD)". The purpose of this study is to evaluate the safety, and tissue effect of the CryoSpray Ablation(TM) System (CryoSpray Ablation(TM), "CSA" or "cryospray therapy") at multiple centers to treat malignant airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber opt...
What is the current status of trial NCT00748085?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2008-10. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00748085?
The interventions under investigation include: CryoSpray Ablation (DEVICE).
Who is sponsoring clinical trial NCT00748085?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.